0
Signin
countryflagUS

18889881171

AAPL 173.18 2.2918% MSFT 397.84 0.7343% GOOG 168.46 1.7455% GOOGL 166.62 1.6844% AMZN 184.72 3.1955% NVDA 858.11 3.3357% META 441.84 0.6034% TSLA 180.1 0.0611% TSM 136.23 0.956% LLY 755.91 -2.683% V 267.61 0.1085% AVGO 1238.3 -0.3669% JPM 191.66 -0.1042% UNH 492.97 1.8302% NVO 124.02 -4.0167% WMT 59.71 1.4613% LVMUY 164.94 0.5609% XOM 116.24 0.181% LVMHF 825.49 0.3843% MA 441.1 -0.2194%

Walgreens Boots Alliance Inc

Healthcare US WBA

17.53USD
0.19(1.10%)

Last update at 2024-05-02T20:11:00Z

Day Range

17.2817.68
LowHigh

52 Week Range

19.6735.41
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Income before tax -5419.00000M 3985.00M 1995.00M 743.00M 4527.00M
Minority interest 448.00M 271.00M 319.00M -32.00000M -20.00000M
Net income -3080.00000M 4337.00M 1328.00M 456.00M 3982.00M
Selling general administrative 34205.00M 27295.00M 24586.00M 27045.00M 25242.00M
Selling and marketing expenses - - - - -
Gross profit 27072.00M 28266.00M 28067.00M 28017.00M 30076.00M
Reconciled depreciation 2257.00M 1990.00M 1973.00M 1927.00M 2038.00M
Ebit -4839.00000M 4385.00M 3481.00M 1312.00M 4998.00M
Ebitda -2582.00000M 6375.00M 5454.00M 3309.00M 7269.00M
Depreciation and amortization 2257.00M 1990.00M 1973.00M 1997.00M 2271.00M
Non operating income net other - 2998.00M 558.00M 70.00M 233.00M
Operating income -6882.00000M 4385.00M 3481.00M 1312.00M 4998.00M
Other operating expenses 146214.00M 131732.00M 129028.00M 138565.00M 132032.00M
Interest expense 580.00M 400.00M 905.00M 639.00M 704.00M
Tax provision -1858.00000M -30.00000M 667.00M 360.00M 588.00M
Interest income - - - 627.00M 549.00M
Net interest income -580.00000M -400.00000M -905.00000M -639.00000M -704.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1858.00000M -30.00000M 667.00M 360.00M 588.00M
Total revenue 139081.00M 132703.00M 132509.00M 139537.00M 136866.00M
Total operating expenses 34205.00M 27295.00M 24586.00M 27045.00M 25242.00M
Cost of revenue 112009.00M 104437.00M 104442.00M 111520.00M 106790.00M
Total other income expense net 2295.00M -400.00000M -1486.00000M -569.00000M -471.00000M
Discontinued operations - - 548.00M 548.00M 548.00M
Net income from continuing ops -3528.00000M 4065.00M 1955.00M 383.00M 3939.00M
Net income applicable to common shares -3080.00000M 4337.00M 2542.00M 456.00M 3982.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Total assets 96628.00M 90124.00M 81285.00M 87174.00M 68239.00M
Intangible assets 13635.00M 10730.00M 9936.00M 10753.00M 10876.00M
Earning assets - - - - -
Other current assets 1126.00M 1060.00M 799.00M 974.00M 1118.00M
Total liab 68138.00M 59716.00M 57463.00M 66038.00M 43446.00M
Total stockholder equity 20021.00M 29366.00M 23822.00M 21136.00M 24152.00M
Deferred long term liab - 1442.00M 1850.00M 1498.00M 1785.00M
Other current liab 8635.00M 7983.00M -1.00000M -1.00000M 5690.00M
Common stock 12.00M 12.00M 12.00M 12.00M 12.00M
Capital stock 12.00M 12.00M 12.00M 12.00M 12.00M
Retained earnings 33058.00M 37801.00M 35121.00M 34210.00M 35815.00M
Other liab 12416.00M 5001.00M 5262.00M 3750.00M 5254.00M
Good will 28187.00M 22280.00M 12421.00M 15268.00M 16560.00M
Other assets 2524.00M 1729.00M 1987.00M 660.00M 640.00M
Cash 728.00M 1358.00M 1193.00M 516.00M 1023.00M
Cash and equivalents - - - - -
Total current liabilities 24535.00M 22583.00M 22054.00M 27070.00M 25769.00M
Current deferred revenue - - 7355.00M 6649.00M -
Net debt 32806.00M 34119.00M 32199.00M 39624.00M 15813.00M
Short term debt 3265.00M 3345.00M 3564.00M 5964.00M 5738.00M
Short long term debt 918.00M 1059.00M 1306.00M 3539.00M 5738.00M
Short long term debt total 33534.00M 35477.00M 33392.00M 40140.00M 16836.00M
Other stockholder equity -10056.00000M -5642.00000M -9202.00000M -9315.00000M -7778.00000M
Property plant equipment 31754.00M 32988.00M 34140.00M 33351.00M 13478.00M
Total current assets 15503.00M 16902.00M 15814.00M 18073.00M 18700.00M
Long term investments 3497.00M 5495.00M 6987.00M 7338.00M 6851.00M
Net tangible assets -23302.00000M 26316.00M 1465.00M 20638.00M 23510.00M
Short term investments 11.00M 1114.00M - - -
Net receivables 5381.00M 5017.00M 5663.00M 7132.00M 7226.00M
Long term debt 8145.00M 10615.00M 7675.00M 12203.00M 11098.00M
Inventory 8257.00M 8353.00M 8159.00M 9451.00M 9333.00M
Accounts payable 12635.00M 11255.00M 11136.00M 14458.00M 14341.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 4091.00M 402.00M 498.00M 641.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2993.00000M -2805.00000M -2109.00000M -3771.00000M -3897.00000M
Additional paid in capital - - - - -
Common stock total equity - 12.00M 12.00M 12.00M 12.00M
Preferred stock total equity - - - - -
Retained earnings total equity - 37801.00M 35121.00M 34210.00M 35815.00M
Treasury stock - -20683.00000M -20593.00000M -20575.00000M -19057.00000M
Accumulated amortization - - - - -
Non currrent assets other 2553.00M 287.00M 137.00M -822.00000M 10225.00M
Deferred long term asset charges - - - - -
Non current assets total 81125.00M 73222.00M 65471.00M 69101.00M 48899.00M
Capital lease obligations 24471.00M 23803.00M 24412.00M 24399.00M -
Long term debt total - 10615.00M 7675.00M 12203.00M 11098.00M
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Investments -3094.00000M -1064.00000M 4072.00M -1297.00000M 3.00M
Change to liabilities 1243.00M 192.00M 842.00M 746.00M 20.00M
Total cashflows from investing activities -3094.00000M -1064.00000M 4072.00M -1297.00000M -2307.00000M
Net borrowings -2703.00000M 1996.00M -7127.00000M -1208.00000M 2508.00M
Total cash from financing activities -887.00000M -1499.00000M -9036.00000M -4647.00000M -3047.00000M
Change to operating activities 5401.00M -73.00000M 712.00M 961.00M -640.00000M
Net income -3528.00000M 4065.00M 2512.00M 424.00M 3962.00M
Change in cash -1702.00000M 1288.00M 524.00M -461.00000M 232.00M
Begin period cash flow 2558.00M 1270.00M 746.00M 1207.00M 975.00M
End period cash flow 856.00M 2558.00M 1270.00M 746.00M 1207.00M
Total cash from operating activities 2258.00M 3899.00M 5555.00M 5484.00M 5594.00M
Issuance of capital stock - - - - -
Depreciation 2257.00M 1990.00M 1973.00M 1927.00M 2038.00M
Other cashflows from investing activities 6336.00M 669.00M 1355.00M 77.00M -608.00000M
Dividends paid -1659.00000M -1659.00000M -1617.00000M -1747.00000M 1643.00M
Change to inventory 287.00M -433.00000M 165.00M 63.00M 141.00M
Change to account receivables 72.00M 808.00M -1451.00000M 163.00M -789.00000M
Sale purchase of stock -150.00000M -187.00000M -110.00000M -1589.00000M -4160.00000M
Other cashflows from financing activities 3580.00M 8707.00M -3928.00000M -158.00000M 74.00M
Change to netincome -4363.00000M -75.00000M 612.00M 2192.00M 521.00M
Capital expenditures 2117.00M 1734.00M 1379.00M 1374.00M 1702.00M
Change receivables - 808.00M -1451.00000M 163.00M -789.00000M
Cash flows other operating - -2648.00000M -46.00000M -31.00000M -299.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes - 1336.00M 591.00M -460.00000M 240.00M
Change in working capital 7444.00M 495.00M 428.00M 941.00M -740.00000M
Stock based compensation 385.00M 391.00M 155.00M 137.00M 119.00M
Other non cash items -1929.00000M -2676.00000M 254.00M 2098.00M 115.00M
Free cash flow 141.00M 2165.00M 4176.00M 4110.00M 3892.00M

Fundamentals

  • Previous Close 17.34
  • Market Cap22946.57M
  • Volume7822495
  • P/E Ratio-
  • Dividend Yield7.32%
  • EBITDA4098.00M
  • Revenue TTM139081.01M
  • Revenue Per Share TTM161.12
  • Gross Profit TTM 27072.00M
  • Diluted EPS TTM-3.57

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
WBA
Walgreens Boots Alliance Inc		 0.19 1.10% 17.53 - 7.60 0.16 1.09 0.39 -21.1795
RADLY
Raia Drogasil SA ADR		 - -% 5.00 47.15 32.68 0.34 9.83 0.35 3.29
ALBBY
Alibaba Health Information Technology Limited		 - -% 6.89 63.53 135.14 0.27 3.41 0.19 5.91
ALBHF
Alibaba Health Information Technology Limited		 0.06 15.49% 0.41 48.00 62.11 0.25 3.04 0.20 6.01
SHPPF
Shop Apotheke Europe N.V		 - -% 148.00 - - 2.80 2.28 1.70 78.78

Reports Covered

Stock Research & News

View All

Profile

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

Walgreens Boots Alliance Inc

108 Wilmot Road, Deerfield, IL, United States, 60015

Key Executives

Name Title Year Born
Mr. Stefano Pessina Exec. Chairman 1941
Ms. Rosalind Gates Brewer CEO & Director 1962
Mr. James Kehoe Exec. VP & Global CFO 1962
Ms. Ornella Barra Chief Operating Officer of International 1953
Mr. Hsiao Wang Sr. VP & Chief Information Officer 1973
Mr. Gerald Gradwell Sr. VP of Investor Relations 1968
Ms. Danielle Carim Gray Exec. VP & Global Chief Legal Officer 1979
Mr. Aaron C. Radelet Global Chief Communications Officer & Sr. VP NA
Ms. Holly May Exec. VP & Global Chief HR Officer 1982
Ms. Mia M. Scholz Sr. VP of Corp. Financial Operations 1966

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).